Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Peter Pickkers¹, Derek C Angus², Kristie Bass³, Rinaldo Bellomo^{4

5}, Erik van den Berg³, Juliane Bernholz³, Morten H Bestle^{6

7}, Kent Doi⁸, Chistopher J Doig⁹, Ricard Ferrer¹⁰, Bruno Francois¹¹, Henrik Gammelager¹², Ulf Goettrup Pedersen¹³, Eric Hoste^{14

15}, Susanne Iversen¹⁶, Michael Joannidis¹⁷, John A Kellum¹⁸, Kathleen Liu¹⁹, Melanie Meersch²⁰, Ravindra Mehta²¹, Scott Millington²², Patrick T Murray²³, Alistair Nichol^{5

24}, Marlies Ostermann²⁵, Ville Pettilä²⁶, Christoffer Solling²⁷, Matthias Winkel³, Paul J Young^{5

28

29

30}, Alexander Zarbock²⁰; REVIVAL investigators

Collaborators, Affiliations

Collaborators

REVIVAL investigators:
Angus Carter, Dietmar Fries, Philip Eller, Ludovic Gérard, Nicolas DeSchryver, Elisabeth Diltoer, Vincent Huberlant, Isabelle Michaux, Patrick M Honore, Tom Fivez, Christopher Doig, Gordon Wood, John Boyd, Alexis Turgeon, Maj Kamper, Thomas Strøm, Sussanne Iversen, Hendrik Gammelager, Bodil Steen Rasmussen, Christoffer Grant Sølling, Morten Hyllander Mæller, Thorbjoern Groefte, Nilanjan Dey, Ulf Gøttrup Pedersen, Mila Valkonen, Panu Uusalo, Ville Jalkanen, Ferhat Meziani, Jermie Lemarie, Gaetan Plantefeve, Konstantimos Bachoumas, Jean Louis Dufour, Anne-Laure Fedou, Pierre Asfar, Xavier Monnet, Christophe Vinsonneau, Sebastien Gibot, Christophe Guitton, Jean-Pierre Quenot, Gregoire Muller, Jean Yves Lefrant, Emmanuelle Mercier, Alexandre Mebazaa, Andreas Kortgen, Sebastian Fichtner, Stefan Kluge, Gernot Marx, Ignatio Martin-Loeches, Bairbre McNicolas, Hidenobu Kamohara, Masahiro Harada, Takuo Nakagami, Shingo Adachi, Kohei Ota, Ryo Furuya, Ayumu Tsuruoka, Yasuaki Mizushima, Satoki Inoue, Pieter Tuinman, F Wim Roozendaal, Bert Beishuizen, Oscar Hoiting, Tom Dormans, Arthur Van Zanten, Paul Young, Anthony Williams, Colin McArthur, Pawel Twardowski, Shay McGuinness, Ricard Ferrer Roca, Carol Lorencio Cardenas, Anna Navas Perez, Fernando Martinez Sagasti, Ingeborg Welters, Matt Wise, Sam Waddy, Niall MacCallum, Raghaven Murugan, Hernando Gomez, Larry Busse, David Boldt, Andrew Bernard, Daniel Files, Benjamin Margolis, Jarrod Mosier, Jonathon Truwit, Felix Zamora, Danielle Davison, Matthew Exline, Nathan Nielsen, Duncan Hite

Affiliations

¹ Department of Intensive Care, Radboudumc, Nijmegen, The Netherlands. Peter.Pickkers@radboudumc.nl.
² Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
³ AM-Pharma, Utrecht, The Netherlands.
⁴ Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
⁵ Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
⁶ Department of Anesthesiology and Intensive Care, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Emergency and Critical Care Medicine, The University of Tokyo, Tokyo, Japan.
⁹ Department of Critical Care Medicine, Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
¹⁰ Department of Intensive Care Medicine, SODIR-VHIR Research Group, Val d'Hebron University Hospital, Barcelona, Spain.
¹¹ Intensive Care, Inserm CIC 1435 & UMR 1092, CHU Limoges, Limoges, France.
¹² Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
¹³ Intensive Care Unit, Zealand University Hospital, Koege, Denmark.
¹⁴ Department of Internal Medicine and Pediatrics, Intensive Care Unit, Ghent University Hospital, Ghent University, Ghent, Belgium.
¹⁵ Research Foundation-Flanders, (FWO), Brussels, Belgium.
¹⁶ Department of Anaesthesiology and Intensive Care, Slagelse Hospital, Slagelse, Denmark.
¹⁷ Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.
¹⁸ Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA.
¹⁹ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
²⁰ Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
²¹ Department of Medicine, University of California San Diego, La Jolla, CA, USA.
²² University of Ottawa/The Ottawa Hospital, Ottawa, Canada.
²³ School of Medicine, University College Dublin, Dublin, Ireland.
²⁴ University College Dublin-Clinical Research Centre at St Vincent's University Hospital, Dublin, Ireland.
²⁵ Department of Critical Care, Guys & St Thomas' Foundation Trust, London, UK.
²⁶ Department of Perioperative and Intensive Care, University of Helsinki and Helsinki University Hospital, HUS, Helsinki, Finland.
²⁷ Department of Anaestesiology and Intensive Care, Viborg Regional Hospital, Viborg, Denmark.
²⁸ Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
²⁹ Medical Research Institute of New Zealand, Wellington, New Zealand.
³⁰ Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.

PMID: 38436728
PMCID: PMC11018672
DOI: 10.1007/s00134-024-07357-z

Published Erratum

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Peter Pickkers et al. Intensive Care Med. 2024 Apr.

. 2024 Apr;50(4):614-615.

doi: 10.1007/s00134-024-07357-z.

Authors

Collaborators

REVIVAL investigators:
Angus Carter, Dietmar Fries, Philip Eller, Ludovic Gérard, Nicolas DeSchryver, Elisabeth Diltoer, Vincent Huberlant, Isabelle Michaux, Patrick M Honore, Tom Fivez, Christopher Doig, Gordon Wood, John Boyd, Alexis Turgeon, Maj Kamper, Thomas Strøm, Sussanne Iversen, Hendrik Gammelager, Bodil Steen Rasmussen, Christoffer Grant Sølling, Morten Hyllander Mæller, Thorbjoern Groefte, Nilanjan Dey, Ulf Gøttrup Pedersen, Mila Valkonen, Panu Uusalo, Ville Jalkanen, Ferhat Meziani, Jermie Lemarie, Gaetan Plantefeve, Konstantimos Bachoumas, Jean Louis Dufour, Anne-Laure Fedou, Pierre Asfar, Xavier Monnet, Christophe Vinsonneau, Sebastien Gibot, Christophe Guitton, Jean-Pierre Quenot, Gregoire Muller, Jean Yves Lefrant, Emmanuelle Mercier, Alexandre Mebazaa, Andreas Kortgen, Sebastian Fichtner, Stefan Kluge, Gernot Marx, Ignatio Martin-Loeches, Bairbre McNicolas, Hidenobu Kamohara, Masahiro Harada, Takuo Nakagami, Shingo Adachi, Kohei Ota, Ryo Furuya, Ayumu Tsuruoka, Yasuaki Mizushima, Satoki Inoue, Pieter Tuinman, F Wim Roozendaal, Bert Beishuizen, Oscar Hoiting, Tom Dormans, Arthur Van Zanten, Paul Young, Anthony Williams, Colin McArthur, Pawel Twardowski, Shay McGuinness, Ricard Ferrer Roca, Carol Lorencio Cardenas, Anna Navas Perez, Fernando Martinez Sagasti, Ingeborg Welters, Matt Wise, Sam Waddy, Niall MacCallum, Raghaven Murugan, Hernando Gomez, Larry Busse, David Boldt, Andrew Bernard, Daniel Files, Benjamin Margolis, Jarrod Mosier, Jonathon Truwit, Felix Zamora, Danielle Davison, Matthew Exline, Nathan Nielsen, Duncan Hite

Affiliations

¹ Department of Intensive Care, Radboudumc, Nijmegen, The Netherlands. Peter.Pickkers@radboudumc.nl.
² Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
³ AM-Pharma, Utrecht, The Netherlands.
⁴ Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
⁵ Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
⁶ Department of Anesthesiology and Intensive Care, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark.
⁷ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
⁸ Department of Emergency and Critical Care Medicine, The University of Tokyo, Tokyo, Japan.
⁹ Department of Critical Care Medicine, Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
¹⁰ Department of Intensive Care Medicine, SODIR-VHIR Research Group, Val d'Hebron University Hospital, Barcelona, Spain.
¹¹ Intensive Care, Inserm CIC 1435 & UMR 1092, CHU Limoges, Limoges, France.
¹² Department of Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
¹³ Intensive Care Unit, Zealand University Hospital, Koege, Denmark.
¹⁴ Department of Internal Medicine and Pediatrics, Intensive Care Unit, Ghent University Hospital, Ghent University, Ghent, Belgium.
¹⁵ Research Foundation-Flanders, (FWO), Brussels, Belgium.
¹⁶ Department of Anaesthesiology and Intensive Care, Slagelse Hospital, Slagelse, Denmark.
¹⁷ Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University of Innsbruck, Innsbruck, Austria.
¹⁸ Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA.
¹⁹ Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
²⁰ Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
²¹ Department of Medicine, University of California San Diego, La Jolla, CA, USA.
²² University of Ottawa/The Ottawa Hospital, Ottawa, Canada.
²³ School of Medicine, University College Dublin, Dublin, Ireland.
²⁴ University College Dublin-Clinical Research Centre at St Vincent's University Hospital, Dublin, Ireland.
²⁵ Department of Critical Care, Guys & St Thomas' Foundation Trust, London, UK.
²⁶ Department of Perioperative and Intensive Care, University of Helsinki and Helsinki University Hospital, HUS, Helsinki, Finland.
²⁷ Department of Anaestesiology and Intensive Care, Viborg Regional Hospital, Viborg, Denmark.
²⁸ Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
²⁹ Medical Research Institute of New Zealand, Wellington, New Zealand.
³⁰ Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia.

PMID: 38436728
PMCID: PMC11018672
DOI: 10.1007/s00134-024-07357-z

No abstract available

PubMed Disclaimer

Erratum for

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
Pickkers P, Angus DC, Bass K, Bellomo R, van den Berg E, Bernholz J, Bestle MH, Doi K, Doig CJ, Ferrer R, Francois B, Gammelager H, Pedersen UG, Hoste E, Iversen S, Joannidis M, Kellum JA, Liu K, Meersch M, Mehta R, Millington S, Murray PT, Nichol A, Ostermann M, Pettilä V, Solling C, Winkel M, Young PJ, Zarbock A; REVIVAL investigators. Pickkers P, et al. Intensive Care Med. 2024 Jan;50(1):68-78. doi: 10.1007/s00134-023-07271-w. Epub 2024 Jan 3. Intensive Care Med. 2024. PMID: 38172296 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Collaborators

Affiliations

Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Authors

Collaborators

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources